Aggression as an adverse drug reaction

Adverse Drug Reactions and Toxicological Reviews

Volumn 19, Issue 1, 2000, Pages 35-45

  Shaw, Susan C ^a   Fletcher, A Peter ^b  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b Hall Corner Cottage ^*  (United Kingdom)

Author keywords

Adverse drug reaction; Aggression; Hostility

Indexed keywords

ALPRAZOLAM; ANABOLIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; CLOBAZAM; CLOMIPRAMINE; CYPROHEPTADINE; DIAZEPAM; FELBAMATE; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; MORPHINE; OXAZEPAM; TEMAZEPAM; VIGABATRIN; ZOPICLONE;

ADVERSE DRUG REACTION; AGGRESSION; REVIEW;

AGGRESSION; ANABOLIC AGENTS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; FLUOXETINE; HUMANS;

EID: 0034107784     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Berkowitz L. The problem of aggression (chapter 1, page 3). In: Aggression: Its causes, consequences and control. New York, McGraw-Hill, 1999.
2. Spielberger IC, Johnson EH, Russell SF, Crane R, Jacobs GA, Worden TJ. The experience and expression of anger: Construction and validation of an anger expression scale. In: NA Chesney, RH Rosenman eds. Anger and hostility in cardiovascular and behavioural disorders. New York, McGraw-Hili 1985; 59-87.
3. Brice AT. The blood fats in schizophrenia. J Nerv Ment Dis 1935; 81: 613-32.
4. Hillbrand M, Spitz RT. Cholesterol and aggression. Aggression Violent Behav 1999; 4: 359-370.
5. Fava M, Abraham BA, Pava J, Shuster J, Rosenbaum J. Cardiovascular risk factors in depression. Psychosomatics 1996; 37: 31-7.
6. Johnson EH, Collier P, Nazarro P, Gilbert DC. Psychological and physiological predictors of lipids in black males. J Behav Med 1992; 15: 285-98
7. Waldstein SR, Manuck SR, Bachen E A, Muldoon MF, Bricker PL. Anger expression, lipids and lipoproteins. Paper presented at the Annual Meeting of the Society of Behavioural Medicine 1990. Chicago, Illinois.
8. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist-to-hip ratio in middle-aged women. Associations with behavioural and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb 1991; 11: 1250-57.
9. Glueck CJ, Kuller FE, Hamer T, Rodriguez R, Sosa F, Seive-Smith L, Morrison JA. Hypercholesterolemia, hypertriglyceridemia, suicide, and suicide ideation in children hospitalized for psychiatric diseases. Pediatr Res 1994; 35: 602-10.
10. Greene RE, Houston BK, Holleran SA. Aggressiveness, dominance, developmental factors and serum cholesterol level in college males. J Behav Med 1995; 18: 569-80.
11. Fowkes FGR, Leng GC, Donnan PT, Deary IJ, Reimersma RA, Housley E. Serum cholesterol, triglycerides and aggression in the general population. Lancet 1992; 340: 995-8.
12. Scherwitz LW, Perkins LL, Chesney MA. Hostility and health behaviours in young adults: the CARDIA study. Am J Epidemiol 1992; 136: 136-45.
13. Rao U, Carlson GA, Rapport MD. Serum cholesterol and aggressive behaviour in psychiatrically hospitalized children. Acta Psychiatr Scand 1991; 83: 77-8.
14. Gray RF, Corrigan FM, Strathdee A, Skinner ER. Cholesterol metabolism and violence: A study of individuals convicted of violent crimes. Neuroreport 1993; 4: 754-6.
15. Virkunnen M. Serum cholesterol in antisocial personality. Neuropsychobiology 1979; 5: 27-30.
16. Virkunnen M. Serum cholesterol levels in homicidal offenders. Biol Psychiatry 1983; 10: 65-9.
17. Virkunnen ME, Penttinen H. Serum cholesterol in aggressive conduct disorder: A preliminary study. Biol Psychiatry 1984; 19; 435-9.
18. Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroe-Blum H. Plasma lipid levels and psychologic characteristics in men. Am J Epidemiol 1995; 141: 507-17.
19. Hillbrand M. Foster HG. Serum cholesterol levels and severity of aggression. Psychol Rep 1993; 72: 270.
20. Hillbrand M, Spitz RT, Foster HG. Serum cholesterol and aggression in hospitalized male forensic patients. J Behav Med 1995; 18: 33-43.
21. Hillbrand M, Waite BM, Miller DS, Spitz RT. Serum-cholesterol concentrations and mood states in violent psychiatric patients: An experience sampling study. J Abnorm Psychol, unpublished.
22. Muldoon MF, Kaplan JR, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. BMJ 1992; 301: 739-42.
23. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R, Yusef F. For participants in the Conference on Low Cholesterol: Mortality Associations. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation 1992; 86: 1046-60.
24. Lindberg G, Rostam L, Gullberg B, Eklund GA. Low serum cholesterol concentration and short term mortality from inquiries in men and women. BMJ 1992; 305: 277-9.
25. Niaura R, Stoney CM, Herbert PN. Lipids in psychological research. Biol Psychol 1992; 34: 1-43.
26. Stoney CM, West S. Lipids, personality and stress: Mechanisms and modulators. In M Hillbrand, RT Spitz (eds). Lipids, Health and Behaviour. Washington DC. Am Psychol Assoc 1997; 47-66.
27. Brown SL, Botsis A, Van Praag HM. Serotonin and aggression. In: M Hillbrand, N Pallone eds. The Psychology of Aggression. New York, Haworth Press. 1995; 27-40.
28. Committee on Safety of Medicines. Zopiclone and neuropsychiatric reactions. Curr Probl 30
29. British National Formulary No. 31 March 1996; Hypnotics and Anxiolytics -diazepam. British Medical Association and Royal Pharmaceutical Society, London 153-4.
30. Bond A, Lader M. Differential effects of oxazepam and lorazepam on aggressive responding. Psychopharmacology 1988; 95: 369-73.
31. Bond AJ, Curran HV, Bruce MS et al. Behavioural aggression in panic disorder after 8 weeks treatment with alprazolam. J Affect Disord 1995; 35: 117-23.
32. Bond AJ, Silveira JC. The combination of alprazolam and alcohol on behavioural aggression. J Stud Alcohol 1993; 11 (suppl): 30-9.
33. ABPI Data Sheet Compendium. (1996-1997). Xanax Data Pharm Publications Ltd., London 826.
34. O'Sullivan GH, Nashiroani H, Basoglu M, Marks IM, Swinson R, Kuch P, Kirby M. Safety and side effects of alprazolam: a controlled study in agoraphobia with panic disorder. Br J Psychiatry 1994; 164: 79-86.
35. Sheth RD, Gouldon KJ and Ronan GM. Aggression in children treated with clobazam for epilepsy. Clin Neuropsychiat 1994; 17: 332-7.
36. ABPI Data Sheet Compendium. (1996-1997). Temazepam. Data Pharm Publications Ltd., London, 1262-3.
37. Gudes Y, Carlhant D. General anaesthetics and therapeutic gases. In: Aransen JK, van Boxtel CJ (eds). Side Effects of Drugs Annual. Elsevier, Amsterdam. 1994; 18: 20.
38. Massanari M, Novitsky J, Reinstein LJ. Paradoxical reactions in children associated with midazolam use during endoscopy. Clin Pediatr (Phila) 1997; 36: 681-4.
39. Elder JS Longenecker R. Premedication with oral midazolam for voiding cystourethography in children: safety and efficacy. Am J Roentgen 1995; 164: 1229-32.
40. Beran RG, Gibson RJ. Aggressive behaviour in intellectualy challenged patients with epilepsy treated with lamotrigine. Epilepsia 1998; 39: 1018-9.
41. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behaviour in pediatric patients with seizures. Epilepsia 1996; 37: 501-2.
42. Lee DO, Steingard RJ, Casena M, Helmers SL, Riviello JJ, Mikati MA. Behavioural side effects of gabapentin in children. Epilepsia 1996; 37: 87-90.
43. Aldenkamp AP, Vermeulen J, Mulder OG, Overweg J, Van Parys JAP, Beun AM, Van't Slot B. Gaba-vinyl-GABA (vigabatrin) and mood disturbances. Epilepsia 1994; 35: 999-1004.
44. Pitkanen A, Ylanen A, Matilainen R, Luukainen R, Mervaala E et al. Longterm antiepileptic efficacy of vigabatrin in drug refractory epilepsy in mentally retarded patients - a five year follow-up. Arch Neurol 1993; 50: 24-29.
45. King JA. Increased incidence of adverse behavioural side effects associated with addition of felbamate to anti-epileptic drug regimens in the mentally subnormal population. Epilepsia 1994; 35 (suppl): 32.
46. Troisi A, Vicario E, Nuccetelli F et al. Effects of fluoxetine on aggressive bevaviour of adult in-patients with mental retardation and epilepsy. Pharmacopsychiatry 1997; 28: 73-6.
47. Fuller RW. The influence of fluoxetine on aggressive behaviour. Neuropsychopharmacology 1997; 16: 374-5.
48. Heligenstein JH, Beasley CM Jr. Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 1993; 8: 277-80.
49. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behaviour in personality disordered subjects. Arch Gen Psychiatry 1997; 54: 1081-8.
50. Cleare AJ, Bond AJ. The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology 1995; 118: 72-81.
51. Strayhorn JM Jr. Case Study: cyproheptadine and aggression in a five year old boy. J Am Acad Child Adolesc Psychiatry 1998; 37: 668-70.
52. Devinsky O, Jernan J, Bear DM. Aggressive behaviour following exposure to cholinesterase inhibitors. J Neuropsychiatr Clin Neurosci 1992; 4: 189-94.
53. Alarcon RD. Johnson BR, Lucas JP. Paranoid and aggressive behaviour in two obsessive-compulsive adolescents treated with clomipramine. J Am Acad Child Adolesc Psychiatry 1991; 30: 999-1002.
54. Berman M, Taylor S and Marged B. Morphine and human aggression. Addict Behav 1993; 18: 263-8.
55. Lamb D. Anabolic steroids in athletes. Am J Sports Med 1984; 12: 31-8.
56. Voy R. Drugs, sport and politics. Human Kinetic Publishers, Illinois; 1991.
57. Pope HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 1988; 145: 487-9.
58. Choi PYL, Parrott AC, Cowan D. High dose anabolic steroids in strength athletes: effects upon hostility and aggression. Hum Psychopharmacol 1990; 5: 349-56.
59. Bahrke MS, Yesalis CE, Wright JE. Psychological and behavioural effects of endogenous testosterone levels and anabolic androgenic steroids among males: a review. Sports Med 1990; 10: 303-37.
60. Perry PJ, Yates WR, Anderson KH. Psychiatric symptoms associated with anabolic steroids: a controlled retrospective study. Ann Clin Psych 1990; 2: 11-7.
61. Strauss RH, Ligett JE, Lanese RR. Anabolic steroid use and perceived effects in 10 weight trained women. JAMA 1985; 253: 2871-73.
62. Strauss RH, Wright JE, Finerman GAM. Anabolic steroid use and health status among 42 weight trained male athletes. Med Sci Sports Exercise 1982; 14: 119.
63. Wilson C, Parrott AC. The psychological effects of anabolic steroids. Paper presented at the Joint Annual Conference of the Psychophysiology Society, Royal Holloway and Bedford New College, London University, September 1991.
64. Parrott AC, Choi PYL, Davies M. (1994) Anabolic steroid use by amateur athletes: effects upon psychological mood states. J Sports Med Phys Fitness; 34: 292-8.